Sector Charles River Laboratories International, Inc.
Aandelen
CRL
US1598641074
Biotechnologie & Medisch Onderzoek
|
Beurs gesloten -
NYSE
22:00:02 02-10-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 290,19 USD | +1,17% |
|
-1,44% | +45,47% |
| 30/09 | Charles River Laboratories International, Inc. : UBS stelt koopadvies voor | ZM |
| 29/09 | PMGC-divisie werkt samen met Charles River Laboratories aan tests van probiotica voor spiergezondheid | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1,17% | -1,44% | +2,78% | +26,67% | +45,47% | +70,22% | +48,07% | -30,36% | +248,20% | 13,69 mld. | |
| +4,16% | +3,04% | +8,38% | +33,66% | +84,62% | +49,37% | +94,17% | +9,52% | - | 74,41 mld. | |
| -3,11% | -2,32% | -7,99% | +2,75% | +13,76% | +23,28% | +77,03% | +210,63% | +5.229,41% | 59,26 mld. | |
| +0,89% | -0,77% | -2,11% | +0,53% | +5,17% | +5,80% | +32,89% | -18,64% | +204,74% | 47,14 mld. | |
| -0,96% | -6,11% | -0,05% | +27,07% | +14,55% | +26,70% | +31,24% | +6,90% | +218,54% | 42,91 mld. | |
| +0,36% | +3,39% | -1,54% | +10,20% | +159,44% | +350,59% | +646,53% | +609,62% | - | 44,13 mld. | |
| -0,20% | -0,53% | -0,16% | +23,16% | +17,86% | +6,84% | +99,07% | +0,38% | +1.062,19% | 40,79 mld. | |
| -0,54% | +2,93% | -2,87% | +4,64% | +5,93% | +9,50% | +50,41% | -10,44% | +144,22% | 30,77 mld. | |
| -2,68% | +5,11% | +10,25% | +57,66% | +73,51% | +33,11% | +19,50% | -56,88% | - | 29,31 mld. | |
| +2,33% | -8,58% | -8,55% | +3,85% | -36,15% | -24,55% | +340,08% | +305,84% | +665,29% | 23,71 mld. | |
| +0,05% | -2,38% | -4,95% | +3,17% | +1,79% | -5,20% | -10,81% | -61,97% | - | 24,33 mld. | |
| -2,42% | -0,49% | +5,12% | +25,39% | +11,35% | +13,62% | -10,01% | -18,11% | +99,73% | 20,81 mld. | |
| +0,23% | -3,40% | +2,79% | +10,28% | +6,73% | +10,22% | +147,58% | +206,43% | +1.907,60% | 16,69 mld. | |
| -0,43% | +0,87% | -11,07% | -4,98% | +174,96% | +131,18% | +326,82% | +1.692,64% | +635,44% | 15,17 mld. | |
| +0,25% | -1,23% | -12,44% | -14,91% | - | - | - | - | - | 14,93 mld. | |
| -3,04% | +1,33% | -3,59% | +8,25% | +20,40% | -8,13% | +516,45% | - | - | 14,84 mld. | |
| +0,43% | -3,68% | +4,61% | +9,35% | +19,97% | +18,71% | +39,93% | -29,30% | +85,14% | 14,57 mld. | |
| +0,17% | -6,82% | +23,06% | +24,40% | +29,77% | -12,91% | - | - | - | 13,8 mld. | |
| +0,78% | +0,76% | +2,64% | +8,21% | +33,22% | +41,72% | +167,23% | +171,08% | +356,53% | 14,36 mld. | |
| +0,39% | +2,29% | +18,33% | +16,52% | -4,20% | -18,23% | +795,99% | +227,89% | +84,85% | 13,31 mld. | |
| Gemiddelde | -0,14% | -1,07% | +1,13% | +13,79% | +35,69% | +37,99% | +189,57% | +189,13% | +841,68% | 28,45 mld. | |
| Gewogen gemiddelde per kap. | +0,06% | -0,70% | +0,55% | +15,73% | +40,29% | +47,86% | +159,34% | +145,95% | +1.265,32% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
